Major Key Players of the Artificial Intelligence in Medicine Market are:
InSilico Medicine, Globavir Biosciences, GNS Healthcare, Flatiron Health, Benevolent AI, Atomwise, Verge Genomics, Cloud Pharmaceuticals, and Recursion Pharmaceuticals.
Tuesday, July 14, 2020
Artificial Intelligence in Medicine Market Advanced Technology and New Innovations by 2025 - InSilico Medicine, Globavir Biosciences
The global artificial intelligence (AI) in medicine market was valued at $719 million in 2017 and is estimated to reach $18,119 million at a CAGR of 49.6% from 2018 to 2025. AI is an intelligent system that applies various human intelligence-based functions such as reasoning, learning, and problem-solving skills. AI technology uses software and different algorithms in the field of pharmaceuticals to support the decision-making processes for existing drugs and repurposing drugs to treat other conditions, along with accelerating the clinical trials process by finding the right patients from several data sources.
Major Key Players of the Artificial Intelligence in Medicine Market are:
InSilico Medicine, Globavir Biosciences, GNS Healthcare, Flatiron Health, Benevolent AI, Atomwise, Verge Genomics, Cloud Pharmaceuticals, and Recursion Pharmaceuticals.
Major Key Players of the Artificial Intelligence in Medicine Market are:
InSilico Medicine, Globavir Biosciences, GNS Healthcare, Flatiron Health, Benevolent AI, Atomwise, Verge Genomics, Cloud Pharmaceuticals, and Recursion Pharmaceuticals.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment